Approaches for Targeting Naegleria fowleri Using Nanoparticles and Artificial Peptides
Open Access
Abstract
Naegleria fowleri is a free-living amoeba which causes primary amoebic meningoencephalitis (PAM). Although PAM is rare, the fatality rate is staggering at over 97%. So, the importance of finding an effective treatment and cure for PAM caused by N. fowleri is a crucial area of research. Existing research on developing novel therapeutic strategies to counter N. fowleri infection is limited. Since the blood–brain barrier (BBB) presents an obstacle to delivering drugs to the site of infection, it is important to employ strategies that can effectively direct the therapeutics to the brain. In this regard, our review focuses on understanding the physiology and mechanisms by which molecules pass through the BBB, the current treatment options available for PAM, and the recent research conducted in the decade of 2012 to 2022 on the use of nanomaterials to enhance drug delivery. In addition, we compile research findings from other central nervous system (CNS) diseases that use shuttle peptides which allow for transport of molecules through the BBB. The approach of utilizing BBB shuttles to administer drugs through the BBB may open up new areas of drug discovery research in the field of N. fowleri infection.Keywords
Funding Information
- NIH (R21AI171538)
This publication has 58 references indexed in Scilit:
- Successful Treatment of Primary Amoebic Meningoencephalitis Using a Novel Therapeutic Regimen Including Miltefosine and VoriconazoleActa Parasitologica, 2022
- Polyaniline (PANI)-conjugated tungsten disulphide (WS2) nanoparticles as potential therapeutics against brain-eating amoebaeApplied Microbiology and Biotechnology, 2022
- Intranasal drug delivery: opportunities and toxicologic challenges during drug developmentDrug Delivery and Translational Research, 2021
- Brain penetrating peptides and peptide–drug conjugates to overcome the blood–brain barrier and target CNS diseasesWIREs Nanomedicine and Nanobiotechnology, 2021
- Polymeric Nanoparticles for Nasal Drug Delivery to the Brain: Relevance to Alzheimer's DiseaseAdvanced Therapeutics, 2020
- Treatment of localized mucormycosis using nasal amphotericin B irrigation in pediatric oncologyPediatric Blood & Cancer, 2020
- Formulation characterization and in vitro evaluation of acacia gum–calcium alginate beads for oral drug delivery systemsPolymers for Advanced Technologies, 2017
- Phage display as a tool to discover blood–brain barrier (BBB)‐shuttle peptides: panning against a human BBB cellular modelPeptide Science, 2017
- Preparation of acacia‐stabilized silver nanoparticles: A green approachJournal of Applied Polymer Science, 2007
- Distribution of hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine in rat tissues during steady-state treatmentCancer Chemotherapy and Pharmacology, 1992